lactic acid has been researched along with topotecan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Iqbal, Z; Khuroo, T; Padhi, S; Panda, AK; Talegaonkar, S; Verma, D | 1 |
Arya, N; Katti, DS | 1 |
Iqbal, Z; Kapoor, R; Padhi, S; Panda, AK; Verma, D | 1 |
Rubinstein, A; Sharon Gabbay, R | 1 |
Jang, JH; Jeong, SH; Lee, YB | 1 |
5 other study(ies) available for lactic acid and topotecan
Article | Year |
---|---|
Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Topics: Animals; Antineoplastic Agents, Hormonal; Biological Transport; Drug Carriers; Female; Humans; Intestinal Absorption; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Tamoxifen; Topoisomerase I Inhibitors; Topotecan | 2014 |
Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Synergism; Humans; Lactic Acid; Lung Neoplasms; Nanocomposites; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Topotecan | 2015 |
Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes.
Topics: Antineoplastic Agents; Area Under Curve; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Half-Life; Humans; Hydrogen-Ion Concentration; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; ROC Curve; Topotecan | 2018 |
Controlling the release rate of topotecan from PLGA spheres and increasing its cytotoxicity towards glioblastoma cells by co-loading with calcium chloride.
Topics: Calcium Chloride; Glioblastoma; Humans; Lactic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Topotecan | 2021 |
Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Topics: Animals; Drug Carriers; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Tissue Distribution; Topotecan | 2021 |